A nurse practitioner-led remote patient monitoring program improves glycemic control in uninsured patients with diabetes ...
At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...
While expensive, this piece of tech has taught me a lot about how to fuel my training ...
Novo Nordisk’s latest price target trim to a Fair Value Estimate of $393.29 from $400.24 reflects a more measured long term revenue growth outlook, even as analysts broadly maintain confidence in its ...
The number of people in hospital in England with flu remains at a record level for this time of year, according to new NHS ...
Discover how Aga Khan University Hospital tackles doctor migration in Africa with competitive pay, world-class equipment, and ...
Zacks Investment Research on MSNOpinion
3 HMO stocks in focus despite rising medical costs, regulatory pressures
The U.S. health insurance industry, referred to as Health Maintenance Organization (HMO), is capitalizing on strategic ...
Zacks Investment Research on MSN
NVO down 42% year to date: Is this an indication to sell the stock?
Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply constraints for its semaglutide-based GLP-1 blockbusters — Ozempic for type II ...
Background Non-communicable diseases (NCDs) are the leading cause of death and morbidity worldwide, responsible for 7 out of ...
The vigorous enforcement of marijuana laws has resulted in four million arrests since the early 1980s. Owing to mandatory-minimum sentences, many of those co ...
New research reveals the unhealthiest alcoholic drinks for Christmas, with some cocktails containing more sugar than a can of ...
People who brought their blood glucose down to a normal level had a lower risk of death from heart disease or hospitalization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results